mogroside-v and Non-alcoholic-Fatty-Liver-Disease

mogroside-v has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies

Other Studies

1 other study(ies) available for mogroside-v and Non-alcoholic-Fatty-Liver-Disease

ArticleYear
Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice.
    Molecules (Basel, Switzerland), 2018, Jul-29, Volume: 23, Issue:8

    Obesity and nonalcoholic fatty liver disease (NAFLD) are highly prevalent and cause numerous metabolic diseases. However, drugs for the prevention and treatment of obesity and NAFLD remain unavailable. In this study, we investigated the effects of mogrosides (luo han guo, LH) in

    Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Anticholesteremic Agents; Body Weight; Diet, High-Fat; Gene Expression Regulation; Hep G2 Cells; Humans; Liver; Male; Mice; Momordica; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Reactive Oxygen Species; Saponins; Sequestosome-1 Protein; THP-1 Cells; Triterpenes

2018